HomeGLUE • NASDAQ
add
Monte Rosa Therapeutics Inc
Previous close
$5.45
Day range
$5.29 - $5.50
Year range
$2.44 - $8.84
Market cap
267.32M USD
Avg Volume
151.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 34.86M | 7.31% |
Net income | -33.25M | -8.02% |
Net profit margin | — | — |
Earnings per share | -0.58 | 7.94% |
EBITDA | -31.02M | -6.89% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 232.41M | -11.57% |
Total assets | 303.76M | -11.28% |
Total liabilities | 124.50M | 75.42% |
Total equity | 179.25M | — |
Shares outstanding | 50.14M | — |
Price to book | 1.53 | — |
Return on assets | -31.36% | — |
Return on capital | -38.21% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -33.25M | -8.02% |
Cash from operations | 29.63M | 223.68% |
Cash from investing | 14.30M | 126.51% |
Cash from financing | 25.17M | 23.19% |
Net change in cash | 69.10M | 220.25% |
Free cash flow | 6.78M | 171.83% |
About
Founded
2019
Headquarters
Website
Employees
133